Achilles Therapeutics’ IPO Caps Investment Wave for Neoantigens
The close of the UK firm Achilles Therapeutics’ €146.9M ($175.5M) initial public offering last month…
15/04/2021 - 5 minutes
The close of the UK firm Achilles Therapeutics’ €146.9M ($175.5M) initial public offering last month…
When Oxford-based Evox Therapeutics announced its €81.1M (£69.2M) Series C round in February, it signaled…